Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C

被引:17
|
作者
Kondo, Y
Kobayashi, K
Kobayashi, T
Shiina, M
Ueno, Y
Satoh, T
Shimosegawa, T
机构
[1] Tohoku Univ, Grad Sch Med, Dept Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Hlth Sci, Sendai, Miyagi 9808575, Japan
[3] Furukawa City Hosp, Dept Internal Med, Fukukawa 9196183, Japan
[4] Sendai Natl Hosp, Dept Gastroenterol, Sendai, Miyagi 9830045, Japan
[5] Sendai Shakaihoken Hosp, Ctr Renal Dis, Sendai, Miyagi 9810912, Japan
来源
关键词
HLA class I allele; HLA-A2; CTL; cellular immune response; Japanese individuals;
D O I
10.1620/tjem.201.109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An essential process for resolution of viral infections is the efficient recognition and elimination of intracellular virus. Recognition of viral antigens in the form of short peptides associated with HLA class I molecule is a major task of CD8(+) cytotoxic T lymphocytes. In this study, we have evaluated the frequency of the HLA class I alleles in patients with chronic hepatitis C. HLA-B51, -B52, -B55, -B56, -B61, B70, -Cw1, -Cw3, and -Cw4 are less frequent in patients with chronic hepatitis C than in Japanese individuals. The frequency of HLA-A2 is slightly lower in the patients but tends to be higher in patients with normal alanine aminotransferase (ALT) level than in those with elevated ALT level (p = 0.07). Other HLA alleles are not significantly different between two groups. Comparison of HLA homozygosity at HLA-A and -B or -C or at two or three loci did not show a significant association with levels of serum ALT or with the clinical outcome of interferon therapy in patients with hepatitis C. These results suggest a possibility that the alterations of host response, which depends on genetic background, influence disease activities of HCV infection.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 50 条
  • [31] Adiponectin serum level in chronic hepatitis C infection and therapeutic profile
    Valentina Peta
    Carlo Torti
    Natasa Milic
    Alfredo Focà
    Ludovico Abenavoli
    World Journal of Hepatology, 2015, (01) : 44 - 52
  • [32] Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients
    Uchino, Koji
    Tateishi, Ryosuke
    Fujiwara, Naoto
    Minami, Tatsuya
    Sato, Masaya
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Kondo, Yuji
    Yoshida, Haruhiko
    Moriya, Kyoji
    Shiina, Shuichiro
    Omata, Masao
    Koike, Kazuhiko
    HEPATOLOGY RESEARCH, 2016, 46 (04) : 259 - 268
  • [33] The Distribution of Hepatitis C Virus Genotypes in Patients with Chronic Hepatitis C Infection
    Kirdar, Sevin
    Yasa, Mehmet Hadi
    Aydin, Neriman
    Korkmazgil, Berna Gultekin
    Ozturk, Serife Barcin
    Omurlu, Imran Kurt
    MEANDROS MEDICAL AND DENTAL JOURNAL, 2015, 16 (03): : 108 - 113
  • [34] Liver pathology in chronic hepatitis C and normal ALT levels
    Kamilrov, Farhod
    Aliev, Bahrom
    Ahmadhodjaev, Jasur
    VIRCHOWS ARCHIV, 2007, 451 (02) : 218 - 218
  • [35] Clinical utility of the AST/ALT ratio in chronic hepatitis C
    Imperiale, TF
    Born, LJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (03): : 919 - 920
  • [36] Treatment of patients with chronic hepatitis C and normal ALT levels
    Tassopoulos, NC
    JOURNAL OF HEPATOLOGY, 1999, 31 : 193 - 196
  • [37] Relating Serum GGT to ALT Activity Enhances Its Predictability on Treatment Outcome in Chronic Hepatitis C Reply
    Everhart, James E.
    Wright, Elizabeth
    HEPATOLOGY, 2014, 59 (03) : 1214 - 1215
  • [38] Serum adiponectin in chronic hepatitis C and B
    Siagris, D.
    Lekkou, A.
    Vafiadis, G.
    Michalaki, M.
    Starakis, I.
    Makri, M.
    Margaritis, V.
    Tsamandas, A.
    Labropoulou-Karatza, C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S542 - S542
  • [39] Serum IL 10 in chronic hepatitis C
    Neuman, MG
    Benhamou, JP
    Shear, NH
    Boyer, N
    Marcellin, P
    JOURNAL OF HEPATOLOGY, 2000, 32 : 175 - 175
  • [40] Serum adiponectin in chronic hepatitis C and B
    Siagris, D.
    Vafiadis, G.
    Michalaki, M.
    Lekkou, A.
    Starakis, I.
    Makri, M.
    Margaritis, V.
    Christofidou, M.
    Tsamandas, A. C.
    Labropoulou-Karatza, C.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (08) : 577 - 583